GLP-1 drugs , or glucagon-like peptide-1 compounds, represent a substantial shift in how we approach type 2 diabetes . These new drugs function to stimulating the body’s own GLP-1 substance , which https://socialaffluent.com/story7373569/glp-1-a-significant-advance-in-diabetes-treatment